XBiotech Inc. — Income Charts
20 quarters of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-100.0% -$300K
$0
Cost of Revenue↓-100.0% -$16K
$0
Gross Profit↓-100.0% -$284K
$0
R&D↑+6.7% +$487K
$8M
D&A↓-12.0% -$53K
$390K
Operating Income↓-5.2% -$426K
$-9M
EBITDA↓-6.2% -$479K
$-8M
Interest Expense
$0
Other Income/Expense↑+137.8% +$5M
$1M
Pretax Income↑+31.2% +$3M
$-7M
Tax Provision↓-87.2% -$2M
$308K
Net Income↓-44.7% -$1M
$-5M
Gross Margin↑+17.9pts
94.7%
Operating Margin↓-2560.8pts
-2720.7%
Net Margin↓-924.0pts
-1067.7%
Effective Tax Rate↑+19.0pts
-4.4%
Deferred Tax Assets
$350K
Deferred Tax Liabilities
$0
ETR (Continuing Operations)↓-3.0pts
-1.0%
ETR Federal Statutory↑+0.0pts
27.0%
Revenue YoY Variation↓-6.7pts
-100.0%
Income YoY Variation↑+8.3pts
-5.2%
Revenue QoQ Variation↓-11.1pts
-100.0%
Income QoQ Variation↑+27.0pts
-0.8%